Showing results (191-200 of 220) with videos related to
Sort By:
Pageof 22
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2026
Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2-positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trialsKensei Yamaguchi, Hirokazu Shoji, Hisateru Yasui, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2021
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical TrialYukihide Kanemitsu, Kohei Shitara, Junki Mizusawa, et al.Journal of Human Genetics|September 11, 2007
Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differencesKeiko Maekawa, Mayumi Saeki, Yoshiro Saito, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 3, 2022
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part)Katsuko Kikuchi, Naoya Yamazaki, Keiko Nozawa, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 8, 2025
Risk of peritoneal recurrence following laparoscopic versus open surgery for stage II/III colorectal cancer: An integrated analysis of three Phase III randomized controlled trials (JCOG2310AS2)Marie Hanaoka, Kozo Kataoka, Junki Mizusawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2024
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018)Atsuo Takashima, Tetsuya Hamaguchi, Junki Mizusawa, et al.European Journal of Cancer (Oxford, England : 1990)|November 23, 2024
Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A)Hidekazu Hirano, Kozo Kataoka, Toshifumi Yamaguchi, et al.Journal of the Anus, Rectum and Colon|July 31, 2026
Clinical Significance of Lymph Node Count in Colon Cancer Surgery: A Tumour Location-stratified Prognostic Analysis Based on an Integrated Phase-III Randomized Controlled Trial (JCOG2310AS3)Kenta Iguchi, Kozo Kataoka, Junki Mizusawa, et al.Gut Pathogens|December 1, 2023
Elevated plasma and bile levels of corisin, a microbiota-derived proapoptotic peptide, in patients with severe acute cholangitisRyo Nishiwaki, Ichiro Imoto, Satoko Oka, et al.Cancer Science|September 15, 2019
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancerTetsuya Hamaguchi, Tadamichi Denda, Toshihiro Kudo, et al.Pageof 22